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Abstract
A fundamental goal in catalysis is the coupling of multiple reactions to yield a desired product. 
Enzymes have evolved elegant approaches to address this grand challenge. A salient example is 
the biological conversion of methane to methanol catalyzed by soluble methane monooxygenase 
(sMMO), a member of the bacterial multicomponent monooxygenase (BMM) superfamily.
sMMO is a dynamic protein complex of three components: a hydroxylase, a reductase, and a 
regulatory protein. The active site, a carboxylate-rich non-heme diiron center, is buried inside the 
251-kDa hydroxylase component. The enzyme processes four substrates: O2, protons, electrons, 
and methane. To couple O2 activation to methane oxidation, timely control of substrate access to 
the active site is critical. Recent studies of sMMO, as well as its homologs in the BMM 
superfamily, have begun to unravel the mechanism. The emerging and unifying picture reveals 
that each substrate gains access to the active site along a specific pathway through the 
hydroxylase. Electrons and protons are delivered via a three-amino acid pore located adjacent to 
the diiron center; O2 migrates via a series of hydrophobic cavities; and hydrocarbon substrates 
reach the active site through a channel or linked set of cavities. The gating of these pathways 
mediates entry of each substrate to the diiron active site in a timed sequence and is coordinated by 
dynamic interactions with the other component proteins. The result is coupling of dioxygen 
consumption with hydrocarbon oxidation, avoiding unproductive oxidation of the reductant rather 
than the desired hydrocarbon.
To initiate catalysis, the reductase delivers two electrons to the diiron(III) center by binding over 
the pore of the hydroxylase. The regulatory component then displaces the reductase, docking onto 
the same surface of the hydroxylase. Formation of the hydroxylase-regulatory component complex 
(i) induces conformational changes of pore residues that may bring protons to the active site; (ii) 
connects hydrophobic cavities in the hydroxylase leading from the exterior to the diiron active 
site, providing a pathway for O2 and methane, in the case of sMMO, to the reduced diiron center 
for O2 activation and substrate hydroxylation; (iii) closes the pore, as well as a channel in the case 
of four-component BMM enzymes, restricting proton access to the diiron center during formation 
of “Fe2O2” intermediates required for hydrocarbon oxidation; and (iv) inhibits undesired electron 
transfer to the Fe2O2 intermediates by blocking reductase binding during O2 activation. This 
mechanism is quite different from that adopted by cytochromes P450, a large class of heme-
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containing monooxygenases that catalyze very similar reactions as the BMM enzymes. 
Understanding the timed enzyme control of substrate access has implications for designing 
artificial catalysts. To achieve multiple turnovers and tight coupling, synthetic models must also 
control substrate access, a major challenge considering that nature requires large, multimeric, 
dynamic protein complexes to accomplish this feat.
Graphical Abstract
1. Introduction
How can reactions among multiple substrates be coupled to generate a desired product? This 
challenge is frequently seen in biocatalysis, especially in achieving the most difficult 
chemical transformations. One example is the biological activation of inert C–H bonds. This 
transformation is catalyzed by several metalloenzymes, including the heme-containing 
cytochromes P450,1-4 the dicopper-containing particulate methane monooxygenase,5,6 and 
the family of non-heme diiron-containing bacterial multicomponent monooxygenases 
(BMMs).7-10 These enzymes couple reactions involving four substrates (eq 1), namely, 
oxygen, protons, electrons, and a hydrocarbon RH.
(1)
Timed control of substrate addition to the active site is essential for coupling O2 activation 
to substrate hydroxylation. Without proper control, the following uncoupled reactions can 
occur (eq 2, 3):2,11,12
(2)
(3)
Such uncoupling could be detrimental to the organism, for example, by wasting reducing 
equivalents and by generating hydrogen peroxide, a reactive oxygen species.
Recently, we have come to understand that the desired coupling (eq 1) involves carefully 
programmed access of substrates to the diiron active sites in the hydroxylase components of 
soluble methane monooxygenase (sMMO) and its homologs in the bacterial multicomponent 
monooxygenase (BMM) superfamily. These enzymes are of great interest in the context of 
the global carbon cycle13 and bioremediation.14,15 They are complex systems typically 
comprising three to four protein components.8,16 The flagship enzyme, sMMO, has three 
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components, a hydroxylase (MMOH), a reductase (MMOR), and a regulatory protein 
(MMOB). The 251-kDa hydroxylase is a homodimer with three subunits (α, β, and γ) in 
each protomer.17,18 Each α subunit hosts a diiron center, where dioxygen is activated and 
substrate hydroxylated. The 38-kDa reductase is responsible for providing two electrons 
during each round of the catalytic cycle. It transfers electrons from the reduced form of 
nicotinamide adenine dinucleotide (NADH) to the diiron center, via its flavin adenine 
dinucleotide (FAD) cofactor in the C-terminal domain and an [Fe2S2] cluster in the 
ferredoxin domain.12,19-22 The third component is a 16-kDa regulatory protein, which 
accelerates dioxygen activation and methane oxidation23 and is critical for coupling.11 Some 
members of the BMM superfamily, such as toluene/o-xylene monooxygenase (ToMO)24 
and toluene-4-monooxygenase (T4mo),25 require an additional Rieske-type [Fe2S2] protein 
for reducing the hydroxylase. Dynamic interactions among these component proteins control 
substrate access to achieve some of the most challenging chemical conversions.
Since our previous Account published in 2007,9 we have learned that coupling in BMM 
enzymes relies critically upon the control of substrate access to the catalytic diiron center. 
Here we describe the entry pathway for each substrate as well as the molecular details of the 
mechanism used to control substrate access. Finally, we compare the tactics used by BMM 
enzymes with those adopted by P450s, a large group of related monooxygenases.
2. Control of electron and proton transfer: gating the pore
Accurate control of electron and proton transfer is vital for tight coupling. Electron transfer 
initiates catalysis by reducing the diiron(III) center in the resting hydroxylase to diiron(II) 
(Scheme 1). In subsequent steps, however, electron transfer is undesired, because extra 
electrons could quench the activated oxygen species in P*, Hperoxo, and Q. Proton transfer is 
required for O2 activation, promoting heterolytic cleavage of the O–O bond in sMMO 
catalysis to generate the methane-oxidizing intermediate Q.26,27 Excess proton transfer 
could quench the activated oxygen species, however, leading to production of H2O and 
H2O2 (eqs 2, 3). Accumulating evidence indicates that electrons and protons are transmitted 
through the pore (Figure 1a,b),28-32 a conserved structural feature in BMM 
hydroxylases,29,32-34 and are gated through the interaction with the regulatory component.
2.1. The electron transfer pathway
The reduction of the diiron(III) center is mediated by the reductase component(s). To 
understand the mechanism of electron transfer control, we first need to identify the reductase 
binding site on the hydroxylase and the electron transfer pathway. As the shortest entry from 
the protein exterior to the diiron center, the pore is the leading candidate for the reductase 
binding site.16
Recent studies of sMMO, T4mo, and ToMO all confirm this proposal. In the case of sMMO, 
the reductase binding site on the hydroxylase was determined by hydrogen-deuterium 
exchange mass spectrometry (HDX-MS).35 The data indicated that the ferredoxin domain of 
the reductase binds to a shallow region at the dimer interface of the hydroxylase, known as 
the “canyon”,17 covering the pore (Figure 1a). A computational docking study supported 
this conclusion (Figure 1c) and revealed that the gating residue of the pore, Glu240, lies 
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nearly on a line between the [Fe2S2] cluster of the MMOR ferredoxin domain and the diiron 
center of MMOH (Figure 1d).35 The importance of the pore residues Asn202 and Gln228 in 
ToMO (Asn214 and Glu240 in sMMO) for reductase binding was demonstrated in a 
biochemical study of ToMO.32
Atomic details of the hydroxylase-reductase complex were revealed in an X-ray 
crystallographic investigation of T4MO.36 Consistent with our findings with sMMO35 and 
ToMO,32,37 the reductase (T4moC) covers the pore region in the complex (Figure 1e). The 
crystal structure further revealed a 12-Å distance between the [Fe2S2] cluster of the 
reductase and the diiron center of the hydroxylase, favorable for biological electron 
transfer.38 The two metal clusters are linked through a hydrogen-bonding network, which 
connects the [Fe2S2] cluster ligand His68 with the diiron center ligand Glu231, mediated by 
the pore residue Gln228 (corresponding to Glu240 in MMOH) (Figure 1f).36
2.2. Control of electron transfer: binding competition at the pore
An understanding of the mechanism by which the BMM proteins control the timing of 
electron transfer required information about interactions between the hydroxylase, reductase, 
and regulatory components. Two models were considered, a non-competitive model 
whereby the regulatory component and the reductase bind to different sites on the 
hydroxylase12 and a competitive model where they compete for the same binding site on the 
hydroxylase. Recent structural studies strongly favor the latter. X-ray crystallographic 
results for the hydroxylase-regulatory protein complex revealed that the regulatory 
component binds to the canyon, the same region where the reductase binds, covering the 
pore. This conserved binding mode occurs in sMMO (Figure 2a),31 T4mo (Figure 2b),29 and 
PH (Figure 2c).39
Multiple biochemical/biophysical characterization experiments further support the binding 
competition. In the case of sMMO, MMOB inhibits MMOR cross-linking to MMOH in a 
dose-dependent manner. The MMOR ferredoxin domain protein can displace MMOB from 
MMOH, as observed in a titration experiment by monitoring fluorescence anisotropy of 
MMOB carrying a fluorescent label.35 Binding competition between the regulatory 
component and the reductase was also reported for T4mo.36 Consistent with the competitive 
model, the regulatory component retards electron transfer from the reductase to the diiron 
center, an effect observed in sMMO 20,35,40 and ToMO.37
Binding competition between the reductase and the regulatory components at the pore 
region of the hydroxylase provides a basis for electron transfer control. By fine-tuning the 
binding affinity, the regulatory component could inhibit reductase binding during O2 
activation, blocking undesired electron transfer to the diiron center. Indeed, the regulatory 
component exhibited increased binding affinity to the hydroxylase after reduction of the 
diiron center in sMMO isolated from Methylococcus capsulatus (Bath).41
2.3. Proton and water transfer through the pore
Oxygen activation requires protons.10,26,27 As the only hydrophilic entry to the diiron 
center, the pore provides the route for proton transfer. Biochemical study of ToMO indicated 
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pore residue Thr201 to be critical for proton transfer during dioxygen activation.34 Kinetic 
isotope effects and pH profiles suggested that another pore residue, Gln228, mediates proton 
ingress to, and water egress from, the active site.32
Structural studies revealed the molecular mechanism of proton transfer. In the case of 
sMMO, crystal structures showed Glu240 to be the gating residue in the pore, playing a key 
role in proton transfer.31 In the absence of other component proteins, this residue is 
hydrogen bonded to a water or hydronium ion on the surface of the hydroxylase.31,42 In 
response to the binding of the regulatory component, the carboxylic side chain of Glu240 
moves inward31 in a manner suggesting a role in delivering a proton to the active site for O2 
activation and, in the process, closes down the pore (Figure 3a) to block undesired water/
hydronium ion ingress that would quench reactive intermediates (Scheme 1).31 A similar 
conformational change may occur when the reductase binds to the hydroxylase. Thus 
Glu240 provides the basis for proton-coupled electron transfer.35
Structures of protein complexes of T4mo revealed additional details. As observed in sMMO, 
the regulatory component and the reductase can both induce inward movement of the pore 
gating residue Gln228.29,36 A water molecule not observed in the free hydroxylase appeared 
in the pore in the hydroxylase-regulatory component (Figure 3b) and hydroxylase-reductase 
(Figure 1f) complexes, providing a putative mechanism for proton transfer. In the case of the 
reduced hydroxylase-regulatory component complex, this water molecule (HOH5) is close 
to the open coordination site for O2 binding (Figure 3b), serving as an likely proton source 
for dioxygen activation.29 The crystal structures also revealed an important role of the 
conserved Thr201 in stabilizing the hydrogen bonding network at the active site,29 providing 
a structural basis for the importance of this residue in proton transfer and dioxygen 
activation.26,34
3. Control of O2 access
After reduction of the hydroxylase, O2 needs to be activated by the reduced diiron center for 
substrate hydroxylation (Scheme 1). How does O2 reach the buried diiron center, and how is 
the access controlled?
3.1. Cavities as the O2 ingress route
Hydrophobic gas molecules, including O2 and CH4, find their path to the diiron center 
through a series of cavities that extend over 36-40 Å through the protein interior. Multiple 
lines of evidence support this pathway. Structural characterization of Xe-pressurized sMMO 
and PH hydroxylases revealed xenon atoms, which are similar to O2 molecules in terms of 
size, hydrophobicity, and polarizability,43 localized in these cavities. Halogenated alkanes, 
substrate analogs for sMMO bearing heavy atoms, can also occupy these cavities.44 
Mutagenesis of residues in each of the three hydrophobic cavities in ToMO altered the 
dioxygen diffusion rate in a manner that correlated with the size of the cavities.45 These 
cavities are observed in all crystallographically characterized BMM hydroxylases and are 
likely to be conserved across the superfamily.30
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3.2. Control of O2 access by the regulatory component
An interesting feature of these cavities was evident from the early studies. In several cases, 
cavities 1 and 2 are disconnected (Figure 4a),30 raising the question of how gas molecules 
could migrate through such a disconnected pathway. The crystal structure of the 
hydroxylase-regulatory component complex of sMMO provided critical insight.31 It 
revealed that, upon binding of the regulatory component MMOB, cavities 1 and 2 become 
connected (Figure 4b). MMOB residues Ser111 and Tyr8, at the interface with MMOH in 
the complex, trigger allosteric changes that alter the conformation of Phe188, the gating 
residue between the two cavities (Fig. 4).
The crystal structure also explains the importance of the N-terminal tail of MMOB. The 
regulatory components of ToMO, T4mo, PH, and most other members of the BMM 
superfamily do not have such tail, but in the case of sMMO, enzyme activity is severely 
compromised when the N-terminal tail is truncated or even partially truncated.31,46,47 The 
N-terminal tail is disordered in free MMOB, as revealed by solution NMR spectral 
studies,48,49 but it adopts an unusual ring-like conformation when bound to the surface of 
MMOH (Fig. 2a).31 A key residue in this tail in sMMO is Tyr8, which triggers allosteric 
changes in MMOH that lead to the changes depicted in Figure 4, with assistance from 
residue Ser111, which resides in the core of the regulatory protein.
Another important finding is that the function of MMOB in facilitating O2 ingress depends 
on the oxidation state of the diiron center. In a study of the MMOH-MMOB complex in 
solution, the conformation of the MMOB N-terminal tail was assessed using nitroxide spin-
labeled MMOB mutants by double electron-electron resonance spectroscopy.41 The data 
revealed that the N-terminal tail switches from a flexible to an ordered conformation in 
response to reduction of the diiron center from the diiron(III) to the diiron(II) state. The 
allosteric alterations observed crystallographically in the MMOH-MMOB complex are 
therefore not occurring for the diiron(III) form of the hydroxylase in solution, because Tyr8, 
a critical residue that induces allosteric changes in MMOH, is disordered and lacking a 
stable contact with the hydroxylase. Thus oxygen, and most likely the structurally similar 
hydrocarbon substrate methane, do not have access to the active site until the diiron center is 
reduced to diiron(II), when the N-terminal tail becomes ordered and Tyr8 forms a stable 
interaction with MMOH. Through such a mechanism, access of O2 and CH4 to the active 
site is coupled to reduction of the diiron center.
4. Hydrocarbon substrate ingress and product egress
The small hydrocarbon CH4 finds its route to the active site through cavities in sMMO. 
Some BMM enzymes, however, process much larger, and in some case polar, hydrocarbons. 
In addition, the hydroxylation products are all more hydrophilic than the original substrate. 
What are the pathways for trafficking these substrates and products to and from the active 
site?
4.1. ToMO/T4MO: through the channel and the cavities
A prominent feature of the four-component toluene monooxygenases ToMO and T4mo is a 
6 – 10 Å-wide, 35 Å-long channel in their hydroxylase components (Figures 5a, b). It 
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extends from the protein surface to the active site and merges with cavities 1 and 2 at their 
junction.28,29 The channel was proposed as the substrate and product migration pathway in 
toluene monooxygenases (TMOs), because the product analog bromophenol occupied the 
channel in a crystal structure of ToMO.28 The possibility that this channel might also serve 
as the O2 access pathway was unsupported by a mutagenesis study of ToMO, where variants 
with narrowed or widened channels did not affect the rate of O2 diffusion to the diiron 
center.45 The cavities, which exist in TMOs as the O2 migration pathway, can also provide 
aromatic substrates access to the active site.50,51 Additional studies indicated the cavities to 
be preferred as the substrate ingress pathway, whereas the more hydrophilic channel was the 
preferred product egress pathway.51
The opening of the channel is also controlled by the regulatory component. Upon formation 
of the hydroxylase-regulatory component complex in T4mo, the channel collapses, making 
it inaccessible to small molecules (Figure 5c).29 This effect blocks solvent access to the 
active site during dioxygen activation, thereby increasing the coupling efficiency. Binding of 
the reductase to the hydroxylase leaves the channel open.36
4.2. PH: through the pore or the cavities?
Similar channels occur in the hydroxylase components of PH and sMMO as revealed by 
computational analysis, but they are more constricted and less likely to be functional.30 In 
the case of PH, the migration pathways for the phenolic substrate and product are unclear. 
One possibility is through the cavities, because halogenated alcohols of different sizes could 
be located by X-ray diffraction in the cavities of the sMMO hydroxylase co-crystals,52 but 
direct evidence for such is lacking in the case of PH. The pore is an alternative option, 
considering its hydrophilicity and the larger opening (6 Å diameter) than the pores that 
occur in other BMM enzymes.39
5. Similar function, different strategies: a comparison with cytochromes 
P450
The heme-containing cytochrome P450 monooxygenases catalyze the same overall reaction 
as BMM enzymes (eq 1), but are distinct in many respects. P450s are 40-55 kDa single-
polypeptide proteins. Most of them do not require a regulatory component, also referred to 
as an effector protein, except for a few cases including P450cam, the reductase of which also 
serves as the effector.53 Moreover, P450s adopt very different tactical approach to 
controlling substrate access to the catalytic heme active site.
In the electron transfer step, delivery of the first electron to the heme iron center is gated by 
substrate binding, which prevents wasteful discharge of the reductant in the absence of 
substrate.1,2,4 Such a gating effect is achieved by displacing a water ligand from the heme 
iron upon substrate binding; as a result, the heme iron switches from low-spin to high-spin 
with a concomitant increase in the redox potential, which favors reduction.54-57 This control 
mechanism is not observed in BMM enzymes. In the subsequent O2 activation step for 
P450s, an Fe(IV)=O species known as Compound I2,58 forms by oxygenation of the reduced 
heme site and subsequent e−/2H+ transfer. Quenching of Compound I (eq 2) by further 
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electron transfer is disfavored over substrate oxidation as a result of the close proximity of 
substrate to this oxidizing species.2,59
Control of proton and water access to the active site is also important for P450s. Without 
proper control, the peroxo intermediate that precedes formation of Compound I is 
quenched, 2 releasing H2O2 (eq 3). The hydrophobicity of the active site2,59 as well as the 
conserved alcohol-acid pair, residues Thr252 and Asp251 in P450cam, 2,4,60 are essential for 
proper proton transfer. In addition, substrate binding expels undesired water molecules from 
the active site61 and, in many cases, induces a closed conformation that shields the active 
site from exposure to exterior solvent. This conformational change has been observed in 
P450cam61-63 and in P450s processing specific substrates,64-67 but may not be relevant to 
P450s processing more diverse substrates.68 Such global conformational dynamics are also 
critical for substrate specificity.62 In contrast, BMM enzymes use the regulatory component 
to block undesired proton and water access during O2 activation, by closing the pore as well 
as the channel in the case of TMO. In addition, the hydroxylases of BMM enzymes do not 
undergo any global conformational changes.
6. Conclusions
BMM enzyme systems form dynamic complexes among their protein components to couple 
reactions of multiple substrates by timely control of their access to the active site. To 
achieve such control, different reactants are routed through different pathways in the 
hydroxylase. Electrons and protons traverse the pore; O2 diffuses through the cavities; and 
hydrocarbon substrates use either the cavities or a special channel. The regulatory 
component gates access to these pathways by reversible binding to the canyon region, which 
includes the pore, in a manner that can be regulated by the oxidation state of the diiron 
center. In a catalytic cycle, the reductase transmits two electrons to the diiron(III) center by 
docking into the canyon. Next, the regulatory component displaces the reductase and 
inhibits excess electron transfer during O2 activation by physically occluding the reductase. 
Through binding to the sMMO hydroxylase, the regulatory component restricts water and 
proton access by closing the pore, and, in the case of T4mo, it collapses a channel accessed 
by the aromatic substrates. Within all BMM hydroxylases, allosteric changes induced by 
binding of the regulatory proteins connect the cavities, facilitating O2 (and CH4 in the case 
of sMMO) access to the diiron center. At the conclusion of a full catalytic cycle, the enzyme 
returns to the diiron(III) state, which lowers the binding affinity of the regulatory component 
to the hydroxylase. The reductase is then able to compete with the regulatory component for 
binding to the canyon, reduce the diiron center, and initiate the next round of catalysis.
Although a unified mechanism is emerging, there are some important outstanding issues. 
For instance, to fully support the proposed mechanism of electron transfer control, it would 
be valuable to have direct evidence that activated oxygen species can be quenched in the 
absence of the regulatory component or, by excess reductase that could displace the 
regulatory component. In addition, each BMM family member has uniquely characterstic 
properties. An example is the unique ability of sMMO to oxidize methane, which may 
reflect the apparent inability to generate intermediate Q in any other enzyme. This property 
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may derive from an as yet unknown distinctive strategy involving control of substrate access 
to the diiron center.
The present understanding of these control mechanisms has the potential to guide the 
engineering of improved biocatalysts for hydrocarbon oxidation using atmospheric oxygen. 
It also poses a great challenge for synthetic modeling of enzymes – how do we achieve 
substrate access control in synthetic models, something that nature accomplishes with the 
invention of large and complex proteins and protein complexes?
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Scheme 1. 
The catalytic cycle of sMMO. Rred and Rox represent the reduced and oxidized reductase 
MMOR, respectively, and B the regulatory component MMOB.
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Figure 1. 
The reductase binding site on the hydroxylase. a) Structure of sMMO hydroxylase (PDB ID 
1MTY), showing an area that is within 12 Å of the diiron center in one of the monomers 
(red) and the reductase binding site suggested by HDX-MS (orange). b) A close-up view of 
the pore in sMMO hydroxylase, showing the three residues that define the pore and Fe1 of 
the diiron center. c) Computationally docked model of the hydroxylase-reductase ferredoxin 
domain protein complex of sMMO. d) A close-up view of the binding interface in the 
docked model shown in c), viewed from the top, showing the [Fe2S2] cluster, the diiron 
center, and selected residues of the hydroxylase. e) Crystal structure of the hydroxylase-
reductase complex of T4mo (PDB ID 4P1B). f) A close-up view of the binding interface in 
the docked model shown in e), viewed from the top.
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Figure 2. 
Crystal structures of the hydroxylase-regulatory component complexes of a) sMMO (PDB 
ID 4GAM), b) T4mo (PDB ID 3DHI), and c) PH (PDB ID 2INP). The hydroxylases are 
shown in cyan, and regulatory components in magenta.
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Figure 3. 
Regulatory component induced conformational changes at the pore. a) A close-up view of 
the pore in the hydroxylase-regulatory component complex of sMMO (PDB ID 4GAM), 
where the pore is closed. b) A close-up view of pore residues and ligands of the diiron(II) 
center in the hydroxylase-regulatory component complex of T4mo (PDB ID 3DHI).
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Figure 4. 
Substrate access through the cavities and the pore is triggered by binding of the regulatory 
component. a) In free hydroxylase of sMMO, cavities 1 and 2 are disconnected, and the pore 
is open (PDB ID 1MTY). Xe atoms were found in cavity 2 in MMOH crystals pressurized 
with Xe gas.44 b) When the regulatory component binds, the cavities are connected and the 
pore is closed (PDB ID 4GAM). The concerted motion of these two alterations is striking.
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Figure 5. 
Channels in TMO. a) The channel in free hydroxylase of ToMO (PDB ID 2INC) and a 
magnified view of the channel in the inset. b) The channel in free hydroxylase of T4mo 
(PDB ID 3DHG). c) The channel in the hydroxylase-regulatory component complex of 
T4mo (PDB ID 3DHH). Channel in one of the hydroxylase monomer are shown; b) and c) 
only show one of the hydroxylase monomer. The channel and pore are shown in green and 
orange, respectively.
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